Skip to main content

Table 5 Clinical events

From: Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography

  Standard of care
(N = 31)
Alirocumab
(N = 30)
Adverse cardiac events 0 0
Cardiac death 0 0
Myocardial infarction 1 0
Ischemia driven target lesion revascularization,   
Treatment-related adverse events 1 2
Nasopharyngitis 1 2
Injection-site reaction 0 1
Back pain 1 1
Transaminase elevation